Abstract
Prioritising is an important part of risk management as it helps us to allocate resources to where they are of most utility. This requires us to quantify the different risks. All severe risks must be addressed as they can threaten the continued existence of the clinic or the life of a patient. However, also insignificant events that are highly likely to occur should be addressed, as they will drain the resources of the clinic. This process only indicates the priorities but does not suggest how to address the risk issue. In assessing risk, we are often hampered by the lack of knowledge of the exact nature of the risks, and quantifying the risk of rare events is problematic. For example, our knowledge of long-term risks of IVF is limited because human IVF has not been practised long enough for data to accumulate on this issue. Also, when assessing outcomes, one must know what to look for, and in many cases, we have a limited knowledge of the processes in human development and their vulnerabilities to our in vitro systems and the endocrine environment we create in ART. In principle, there are three ways of managing risk: elimination, reduction and transfer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ESHRE position paper 2008. Good clinical treatment in assisted reproduction. http://www.eshre.eu/binarydata.aspx?type=doc&sessionId=ikjoq445p2t0mxjcr02o3h45/Good_Clinical_treatment_in_Assisted_Reproduction_ENGLISH_new.pdf. Accessed 26 Oct 2010.
Gleicher N, Barad D. Twin pregnancy, contrary to consensus, is a desirable outcome in infertility. Fertil Steril. 2009;91(6):2426–31.
Sauer MV. Italian Law 40/2004: a view from the ‘Wild West’. Reprod Biomed Online. 2006;12(1):8–10.
Miles HL, Hofman PL, Peek J, et al. In vitro fertilization improves childhood growth and metabolism. J Clin Endocrinol Metab. 2007;92(9):3441–5.
Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE, Delemarre-van de Waal HA. Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab. 2008;93:1682–8.
Braat DD, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod. 2010;25:1782–6.
Adams S, Carthey J. IVF witnessing and electronic systems—final report 2006. http://www.hfea.gov.uk/docs/Witnessing_samples_id_report.pdf. Accessed 27 Oct 2010.
de Mouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, Kupka M, Nygren KG, Nyboe Andersen A; European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod. 2010;25:1851–62.
Swain JE, Pool TB. ART failure: oocyte contributions to unsuccessful fertilization. Hum Reprod Update. 2008;14:431–46.
U.S. Chemical Safety and Hazard Investigation Board. Hazards of nitrogen asphyxiation. Safety Bulletin No. 2003-10-B: June 2003. http://www.csb.gov/assets/document/SB-Nitrogen-6-11-03.pdf. Accessed 27 Oct 2010.
Tomlinson M. Risk management in cryopreservation associated with assisted reproduction. Cryo Lett. 2008;29:165–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sjoblom, P., Hreinsson, J. (2012). Risk and Safety in the IVF Clinic. In: Nagy, Z., Varghese, A., Agarwal, A. (eds) Practical Manual of In Vitro Fertilization. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1780-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1780-5_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1779-9
Online ISBN: 978-1-4419-1780-5
eBook Packages: MedicineMedicine (R0)